TUMOR-NECROSIS-FACTOR AND CARDIAC-FUNCTION

被引:31
作者
DEMEULES, JE [1 ]
PIGULA, FA [1 ]
MUELLER, M [1 ]
RAYMOND, SJ [1 ]
GAMELLI, RL [1 ]
机构
[1] UNIV VERMONT,COLL MED,DEPT SURG,BURLINGTON,VT 05405
关键词
D O I
10.1097/00005373-199206000-00003
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The direct effect of tumor necrosis factor (TNF), a product of activated macrophages, on myocardial performance was determined using an isolated papillary muscle technique and a modified Langendorff preparation. Papillary muscle was obtained from male adult rats 4-5 hours after they received either 100 ng/kg TNF (group A), or 100-mu-g/kg TNF (group B) or saline (control). Group B animals exhibited significantly greater peak tension development and velocity of contraction compared with controls (p < 0.05). In group A animals these variables were not significantly different from those of the controls (p > 0.05). Electrophysiologic measurements revealed a significant decrease in resting membrane potential in both group A and group B animals compared with the controls (p < 0.05). Whole hearts perfused with serum from animals treated with TNF 18-22 hours earlier exhibited significant impairment of contractility, decreased rate of systolic pressure development, and decreased rate of relaxation compared with the controls (p < 0.05). Coronary flow and myocardial water content were similar for both groups of perfused hearts. These data suggest that tumor necrosis factor stimulates an early beneficial effect on myocardial function, which 18-22 hours later is associated with impairment of myocardial performance. This effect appears to be serum transferable.
引用
收藏
页码:686 / 692
页数:7
相关论文
共 17 条
  • [1] PURIFICATION OF CACHECTIN, A LIPOPROTEIN-LIPASE SUPPRESSING HORMONE SECRETED BY ENDOTOXIN-INDUCED RAW 264.7 CELLS
    BEUTLER, B
    MAHONEY, J
    LETRANG, N
    PEKALA, P
    CERAMI, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (05) : 984 - 995
  • [2] BEUTLER B, 1987, NEW ENGL J MED, V316, P379
  • [3] BEUTLER B, 1986, CLIN RES, V34, P49
  • [4] BEUTLER B, 1985, J IMMUNOL, V135, P879
  • [5] CREAVEN PJ, 1987, CANCER CHEMOTH PHARM, V20, P137
  • [6] PHASE-I STUDY OF RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR
    KIMURA, K
    TAGUCHI, T
    URUSHIZAKI, I
    OHNO, R
    ABE, O
    FURUE, H
    HATTORI, T
    ICHIHASHI, H
    INOGUCHI, K
    MAJIMA, H
    NIITANI, H
    OTA, K
    SAITO, T
    SUGA, S
    SUZUOKI, Y
    WAKUI, A
    YAMADA, K
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 20 (03) : 223 - 229
  • [7] EFFECTS OF FLUID RESUSCITATION ON CARDIAC DYSFUNCTION FOLLOWING THERMAL-INJURY
    MUELLER, M
    SARTORELLI, K
    DEMEULES, JE
    GAMELLI, RL
    [J]. JOURNAL OF SURGICAL RESEARCH, 1988, 44 (06) : 745 - 753
  • [8] OMALLEY WE, 1962, J NATL CANCER I, V29, P1169
  • [9] SCHIRMER WJ, 1989, ARCH SURG-CHICAGO, V124, P445
  • [10] CACHECTIN - A HORMONE THAT TRIGGERS ACUTE SHOCK AND CHRONIC CACHEXIA
    TRACEY, KJ
    LOWRY, SF
    CERAMI, A
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (03) : 413 - 420